RocketTickers

RedHill Biopharma Receives FDA Approval for COVID-19 Clinical St

Long
NASDAQ:RDHL   Redhill Biopharma Ltd
RDHL: RedHill Biopharma Ltd.
2020-05-08 07:00:10
RedHill Biopharma Receives FDA Approval for COVID-19 Clinical Study with Opaganib in the U.S.